HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Dubreuil Selected Research

masitinib

6/2015A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.
9/2014Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial.
6/2012Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.
1/2012Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study.
11/2008Masitinib is safe and effective for the treatment of canine mast cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Dubreuil Research Topics

Disease

5Neoplasms (Cancer)
01/2012 - 10/2001
4Mastocytosis
09/2019 - 05/2007
3Systemic Mastocytosis
09/2019 - 10/2010
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 05/2007
2Osteoporosis
06/2019 - 10/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2015 - 01/2012
2Sarcoma (Soft Tissue Sarcoma)
06/2012 - 04/2010
2Breast Neoplasms (Breast Cancer)
09/2011 - 01/2007
2Infections
12/2006 - 06/2001
1Cutaneous Mastocytosis
01/2021
1Hypoalbuminemia
11/2016
1Inflammation (Inflammations)
11/2016
1Mast Cell Activation Disorders (Mast-Cell Disease)
03/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2016
1Pain (Aches)
06/2015
1Adenocarcinoma
06/2015
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2014
1Histiocytic Sarcoma
01/2012
1Carcinoma (Carcinomatosis)
01/2012
1Osteosarcoma (Osteogenic Sarcoma)
01/2012
1Neoplasm Metastasis (Metastasis)
09/2011
1Insulin Resistance
01/2010
1Vomiting
11/2008
1Diarrhea
11/2008
1Cytomegalovirus Infections (Inclusion Disease)
12/2006
1Cryptosporidiosis
11/2006
1Weight Gain
11/2006
1Bovine Mastitis
07/2001
1Peritonitis
10/2000

Drug/Important Bio-Agent (IBA)

5masitinibIBA
06/2015 - 11/2008
4Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2007
3Tryptases (Tryptase)IBA
01/2021 - 01/2016
2Biological ProductsIBA
09/2019 - 06/2019
2Tryptophan (L-Tryptophan)FDA Link
11/2016 - 03/2016
2GemcitabineFDA Link
06/2015 - 01/2012
2Tyrosine Kinase InhibitorsIBA
09/2014 - 01/2012
2Imatinib Mesylate (Gleevec)FDA Link
09/2014 - 05/2007
2afadinIBA
09/2011 - 01/2007
1Serotonin (5 Hydroxytryptamine)IBA
11/2016
1KynurenineIBA
03/2016
1Acyl-CoA OxidaseIBA
06/2015
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
06/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2012
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2012
1Diphosphonates (Bisphosphonates)IBA
10/2010
1Phosphotransferases (Kinase)IBA
04/2010
1Cell Surface ReceptorsIBA
04/2010
1tyrosine receptor (receptor, tyrosine)IBA
04/2010
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2010
1Anabolic AgentsIBA
01/2010
1Insulin (Novolin)FDA Link
01/2010
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2008
1thiamine triphosphorate (TTP)IBA
11/2008
1Pharmaceutical PreparationsIBA
05/2007
1Semaxinib (SU5416)IBA
05/2007
1Viral DNAIBA
12/2006
1DNA (Deoxyribonucleic Acid)IBA
12/2006
1halofuginoneIBA
11/2006
1DecoquinateIBA
11/2006
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
10/2001
1Indicators and Reagents (Reagents)IBA
07/2001
1Protein Isoforms (Isoforms)IBA
06/2001
1Complementary DNA (cDNA)IBA
06/2001

Therapy/Procedure

3Therapeutics
10/2010 - 10/2000
1Transplantation
01/2016